GLUT-1 expression in the cerebra of patients with Alzheimer's disease.
about
Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1Metabolic reserve as a determinant of cognitive agingThe pericyte: a forgotten cell type with important implications for Alzheimer's disease?Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's diseaseNeurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersBridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialB-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice.The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's diseaseSimilar ultrastructural breakdown of cerebrocortical capillaries in Alzheimer's disease, Parkinson's disease, and experimental hypertension. What is the functional link?Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differencesFunctional recovery of cholinergic basal forebrain neurons under disease conditions: old problems, new solutions?Reactivation of atrophic neurons in Alzheimer's disease.Brain and behavioral perturbations in rats following Western diet access.Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease.GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degenerationBlood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy.Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial.Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer's disease: metabolic basis for dementia.Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease.Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease.Fluoride Alteration of [3H]Glucose Uptake in Wistar Rat Brain and Peripheral Tissues.Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy.The role of glucose transporters in brain disease: diabetes and Alzheimer’s Disease.Age-dependent metabolic dysregulation in cancer and Alzheimer's disease.Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.Peripheral glucose administration stimulates the translocation of GLUT8 glucose transporter to the endoplasmic reticulum in the rat hippocampus.Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction.The effect of aging on brain barriers and the consequences for Alzheimer's disease development.The blood-brain barrier in Alzheimer's disease.Age-associated physiological and pathological changes at the blood-brain barrier: A review.Significant reduction of the GLUT3 level, but not GLUT1 level, was observed in the brain tissues of several scrapie experimental animals and scrapie-infected cell lines.Epigenetic regulation of the glucose transporter gene Slc2a1 by β-hydroxybutyrate underlies preferential glucose supply to the brain of fasted mice.Cytoprotective effects of hesperetin and hesperidin against amyloid β-induced impairment of glucose transport through downregulation of neuronal autophagy.Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E ɛ4 Carriers.Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
P2860
Q26800063-F81C8864-6CB8-4CE6-A9E8-211807D5C5CAQ26825730-1E240794-B468-4CF9-8F77-A9E51FB63625Q26852369-FB71D021-8782-419C-9911-129F0BFD4907Q28087176-32B2DC4F-4E1B-492B-9100-3A1FE27FA8D3Q29615839-E38F8DAA-E3BB-4063-9F93-5F197B8990A5Q29994589-EDEF7182-0C3E-4C27-9E8D-9BCE09F293FFQ30483111-9C2D2E57-07C5-4870-A834-F0DF459579EDQ33600053-5108D0F2-DD1F-4051-AD4B-AA245D4CFEE2Q33862071-D5B1812E-C7AE-4B1B-B1F6-643174669193Q33922675-E5AB582A-41BB-4D0A-B060-98BA871490F0Q34608061-5463A03A-C9A9-4B03-9478-1C07925440EAQ34771671-5793C597-8D71-469B-8774-5583F786EFD8Q35540380-D18732DC-3ED1-47DD-8A12-18FF9E201524Q35988455-A5DD2BCF-B30B-4208-857A-EA0B59BEF219Q36330297-BB5985CB-E084-4ADB-8DED-93F692170B5EQ36468141-270CB118-90D0-45C2-A6B8-4AA13D7B0E9DQ36526013-2713C51A-7530-45D7-9C6B-45089560679BQ36822317-B07C1F78-4FCA-488F-ADFD-1FA41DE6DEA1Q36913723-F236CD34-63F2-4480-9945-2D3164CD3192Q36928283-2A1B64DA-93D6-4ACC-A627-E9115FB3C22CQ36985886-42AEF05B-EAF6-473D-AF53-AEB4664366FEQ37216153-62036DB7-3C53-422E-A240-2FAE941A77BFQ37382673-DADA146D-619F-44B3-9A93-8D232F071939Q37413705-BC75E6F3-2927-4BD2-A245-C25CD042FEA9Q37714574-CC301A57-C672-429A-A5CC-15F9C94D42EBQ38029187-B78D4188-2E3C-48B9-974B-5016EE5E8A95Q38064315-81113CD7-3A18-4CC6-9BE4-9E8A8278A2CFQ38259091-AA261056-7B03-43F5-86B0-5C65B0365BA8Q38260539-CBA7F678-A065-4BD8-9280-32BD4F923EF0Q38453945-2DCA9664-136D-4841-8AB1-8807318AFD5DQ38708393-0B6E87E1-7BE1-4E76-A9B1-A4CC6A29CED3Q38809233-E747B006-E498-4DB4-8EFD-22D4D6E54865Q38824861-2417EFF8-3743-4EA0-A535-8DA604748C9BQ38899745-2639C917-4AD4-4168-B9E4-D567F81D6D82Q39005977-EF3B1C43-2447-4B2C-8034-A64B45955EDAQ39062180-3D1BAB22-7BCE-4B15-BB65-02D68497223EQ39115885-12B12834-DD51-48FD-8DAD-8442B5EFBCE3Q39387188-3EF122C9-FF72-4FC4-9E38-3656CE5B09E7Q39810517-351531C1-FF67-4771-A082-03C94EF8EF7AQ41660607-D64FD734-BA7A-4A8B-BC35-C0BF08490E0E
P2860
GLUT-1 expression in the cerebra of patients with Alzheimer's disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
GLUT-1 expression in the cerebra of patients with Alzheimer's disease.
@en
GLUT-1 expression in the cerebra of patients with Alzheimer's disease.
@nl
type
label
GLUT-1 expression in the cerebra of patients with Alzheimer's disease.
@en
GLUT-1 expression in the cerebra of patients with Alzheimer's disease.
@nl
prefLabel
GLUT-1 expression in the cerebra of patients with Alzheimer's disease.
@en
GLUT-1 expression in the cerebra of patients with Alzheimer's disease.
@nl
P2093
P1476
GLUT-1 expression in the cerebra of patients with Alzheimer's disease.
@en
P2093
P304
P356
10.1016/S0197-4580(97)00111-5
P577
1997-09-01T00:00:00Z